BioSpace News Archive

Magnolia Medical Technologies, Inc., today announced a $46 million growth equity financing co-led by RTW Investments, LP (“RTW”) and Sectoral Asset Management with significant participation by new investor Janus Henderson Investors.

The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the proteome, announced the company will be participating virtually in the upcoming 42nd Annual Cowen Health Care Conference.

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the appointments of Samuel D. Riccitelli as Interim President and Chief Executive Officer, succeeding Michael W. Nall, and Antonino Morales as Interim Chief Financial Officer, succeeding Timothy C. Kennedy.

Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced an update on the Company’s clinical programs, manufacturing processes and pipeline.

Health Canada is advising patients who use MiniCap Extended Life Peritoneal Dialysis Transfer Sets, manufactured by Baxter Corporation, that direct contact between the sets and certain cleaning products, including hand sanitizers and solvents, may damage the sets.

Counties that introduced a mask mandate early in the pandemic experienced lower COVID-19 case incidence in the six weeks after introduction compared to counties without mandates, according to a new study in Health Affairs from researchers at PolicyLab at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania’s Perelman School of Medicine.

Scientists have found whole genome sequencing (WGS) can quickly and accurately detect the most common inherited neurological disorders – something previously thought to be impossible – with the results supporting the use of WGS as a standard diagnostic tool within routine clinical practice.

Moderna, Inc. announced that the Therapeutic Goods Administration in Australia has granted provisional registration for the use of Moderna’s mRNA COVID-19 vaccine, Spikevax, in a 50 µg dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years.